172 related articles for article (PubMed ID: 7691702)
1. The somatotropin-somatomedin axis in adult patients with Turner syndrome: measurement of stimulated GH, GH-BP, IGF-I, IGF-II and IGFBP-3 in 25 patients.
Holl RW; Kunze D; Blum WF; Benz R; Etzrodt H; Heinze E
Horm Res; 1993; 39(1-2):30-5. PubMed ID: 7691702
[TBL] [Abstract][Full Text] [Related]
2. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
3. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.
Toogood AA; Jones J; O'Neill PA; Thorner MO; Shalet SM
Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868
[TBL] [Abstract][Full Text] [Related]
4. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
[TBL] [Abstract][Full Text] [Related]
5. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
6. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
[TBL] [Abstract][Full Text] [Related]
7. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
8. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
Saggese G; Federico G; Cinquanta L
Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
[TBL] [Abstract][Full Text] [Related]
9. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the IGF system in 15 patients with Alström syndrome.
Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
[TBL] [Abstract][Full Text] [Related]
11. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction.
Argente J; Caballo N; Barrios V; Pozo J; Muñoz MT; Chowen JA; Hernández M
J Clin Endocrinol Metab; 1997 Jul; 82(7):2076-83. PubMed ID: 9215275
[TBL] [Abstract][Full Text] [Related]
12. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation.
Argente J; Caballo N; Barrios V; Muñoz MT; Pozo J; Chowen JA; Morandé G; Hernández M
J Clin Endocrinol Metab; 1997 Jul; 82(7):2084-92. PubMed ID: 9215276
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome).
Savage MO; Blum WF; Ranke MB; Postel-Vinay MC; Cotterill AM; Hall K; Chatelain PG; Preece MA; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1465-71. PubMed ID: 7505286
[TBL] [Abstract][Full Text] [Related]
15. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.
Foster CM; Borondy M; Markovs ME; Hopwood NJ; Kletter GB; Beitins IZ
Pediatr Res; 1994 Feb; 35(2):218-22. PubMed ID: 7513079
[TBL] [Abstract][Full Text] [Related]
17. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
Wilson ME
J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
[TBL] [Abstract][Full Text] [Related]
19. The effects of subcutaneous insulin-like growth factor-I infusion in insulin-dependent diabetes mellitus.
Bach MA; Chin E; Bondy CA
J Clin Endocrinol Metab; 1994 Oct; 79(4):1040-5. PubMed ID: 7525624
[TBL] [Abstract][Full Text] [Related]
20. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
